Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 614 participants.

Also called NCT01300013

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 614 participants (enrolled count) (from the registry)
Sponsor
  • Cytokinetics Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01300013
Other papers using this trial's data
  • Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study Journal of the American College of Cardiology, 2016-03-29 DOI, PubMed 27012405

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Australia, Belgium, Bulgaria, Canada, Czechia, Finland, France, Germany, Greece, Hungary, Italy, Lithuania, Netherlands, Norway, Poland, Russia, Slovakia, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01300013. Randomized; quadruple masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2013-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF)
Condition
Heart Failure
Intervention (Drug)
Placebo
Intervention (Drug)
Omecamtiv mecarbil
Lead sponsor
Cytokinetics (class: industry)

Record details

Record id
cardio:ct-nct01300013
Content hash
b85e83eb13f5c2a76553596c66a6f72e423ef260bed15192edd8fb5a136656c9